Previous close | 17.40 |
Open | 13.65 |
Bid | 13.20 |
Ask | 13.65 |
Strike | 105.00 |
Expiry date | 2025-06-20 |
Day's range | 13.65 - 13.65 |
Contract range | N/A |
Volume | |
Open interest | 40 |
Moderna ( NASDAQ:MRNA ) First Quarter 2024 Results Key Financial Results Revenue: US$167.0m (down 91% from 1Q 2023...
Despite a significant revenue drop, Moderna showcases robust clinical progress and strategic collaborations.
The drugmaker is optimistic about higher sales with new vaccines and a little help from AI in the coming years.